Ammonium Transporters: A molecular dual carriageway
In order to enter a cell, an ammonium ion must first dissociate to form an ammonia molecule and a hydrogen ion (a proton), which then pass through the cell membrane separately and recombine inside.
- School of Biochemistry, University of Bristol, United Kingdom
Ammonium is an important metabolite for all forms of life. It acts as a major source of nitrogen for plants, fungi and bacteria, while in animals, it is used to maintain the pH balance inside cells (and is often produced as a toxic by-product of cellular processes). Each cell is surrounded by a membrane that is impermeable to charged particles like ammonium, so the uptake or release of such molecules requires specialized transporter proteins embedded in the membrane.
Following the pioneering work of biochemists and biophysicists, notably Peter Mitchell and Ronald Kaback, and a wealth of atomic structures revealed by X-ray crystallography and electron cryo-microscopy, the dynamic and biochemical actions of many biological transporters are well understood. So much so, it is rare nowadays to encounter a surprising new mechanism underlying solute transport. Now, in eLife, Ulrich Zachariae, Arnaud Javelle and colleagues at the University of Dundee, University of Strathclyde and Université Libre de Bruxelles, report just such a new mechanism for proton-driven ammonium transport (Williamson et al., 2020).
Even though the first atomic structure of an ammonium transporter was published 16 years ago, exactly how ammonium is transported could not be agreed on (Khademi et al., 2004). To cross the cell membrane, ammonium must pass through the centre of the transporter protein, which is very hydrophobic and therefore unfavourable to the passage of charged molecules. This led to the proposal that ammonium (with the chemical formula NH4+) dissociates into ammonia (NH3) and a positively charged hydrogen ion (H+), with only uncharged NH3 traversing the membrane (Khademi et al., 2004). The importance of this deprotonationevent is supported by other experimental evidence (Ariz et al., 2018). Yet, other studies have shown that for many ammonium transporters, movement of NH3 across the membrane is electrogenic, i.e., accompanied by a flow of positive charge generating an electric current (Ludewig et al., 2002).
The team, which includes Gordon Williamson, Giulia Tamburrino, Adriana Bizior and Mélanie Boeckstaensas joint first authors, reconcile these observations into a single, convincing model by showing that ammonium is first deprotonated on one side of the membrane, and that NH3 and H+ both travel across separately, whereupon they reunite to reform ammonium (Figure 1). Williamson et al. used detailed computer simulations to generate predictions for how transport is achieved, which were then validated in functional and electrophysiological analyses. As such, this work is an excellent example of how integrating computational and empirical observations can produce insights that would otherwise be very difficult to attain.
Figure 1
The mechanism of ammonium transporters.
Ammonium is an important metabolite for many organisms. Until now, it was unclear how exactly ammonium is transported in and out of cells. Williamson et al. demonstrated that ammonium (NH4+) dissociates into ammonia gas (NH3) and a positively charged hydrogen (H+), which then traverse the cell membrane separately and re-join at the other end. (A) The ammonium transporter (teal) spans the whole membrane (grey). The two ends are open to the water-filled environment (cyan), but the only open passage through the centre is strongly water-repellent (pink). The entrance to the water channel has a pocket that specifically recognizes ammonium. (B) Ammonium binds into the pocket near the amino acid Asp160, which is essential to trigger the opening of the channel. The environment inside the pocket also allows ammonium to separate into NH3 and H+. NH3 can now cross the membrane through the hydrophobic channel (pink), and H+ crosses separately via the bridge formed of two copies of the amino acid histidine (His168 and His318). (C) Once inside the cell, NH3 and H+ recombine to make ammonium (NH4+).
A critical feature of any metabolite transporter is that it does not accidentally transport other molecules. This is a particular danger for potassium ions (K+), which are a similar size and shape to ammonium, but also for protons, which must cross the membrane as part of the transport reaction. The concentrations of these ions are tightly regulated inside cells, so even small leaks of either would be detrimental to most cells. The results of Williamson et al. reveal just how this selectivity is achieved. For example, the water-filled channel through which H+ moves is only formed when ammonium binds at the entrance to the transporter. The formation of the channel depends on a single amino acid, which is present in all known ammonium transporters: even a conservative amino acid substitution at this site completely stops the transporter from working (Figure 1A).
To prevent any potassium from leaking through, the fully formed water channel is blocked at its centre by two copies of the amino acid histidine (Figure 1B). Histidine readily takes up and releases protons at physiological (slightly basic) pH values (pH 7.4), so H+ can hop across the histidine bridge with relative ease. But the twin histidines block anything larger from getting through. If both of them are removed, the transporter becomes an open channel, letting both protonated ammonium and potassium flow through freely (Williamson et al., 2020).
Ammonium transporters share a similar three-dimensional structure, even in organisms with distant evolutionary origins. But it remains to be seen how widespread this specific transport mechanism is: do most ammonium transporters work in the same way, or are there some that transport NH3 while leaving the proton behind? And what structural features determine this? Also, further research is needed to determine how exactly the channel forms, how the proton is removed from the ammonium, and how the speed at which ammonium crosses the membrane is regulated. The breakthrough by Williamson et al. opens the door to these questions that could lead towards a complete understanding of a fundamental biological process widespread throughout nature.
Ammonium transporters are relevant to numerous, disparate scientific fields. For example, the central role ammonium plays in the global nitrogen cycle makes them important both for improving crop yields and for the breakdown of pollutants (Li et al., 2017; Fowler et al., 2013). Human ammonium transporters are essential for kidney function, and mutations have been implicated in various diseases (Kurtz, 2018; Huang and Ye, 2010). For those interested in other membrane transport processes, the idea of using selective protonation or deprotonation of small, ionisable solutes, or even the amino acid side chains of larger protein molecules, is compelling (Jiang et al., 2015; Wiechert and Beitz, 2017).
References
-
The global nitrogen cycle in the twenty-first centuryPhilosophical Transactions of the Royal Society B: Biological Sciences 368:20130164.https://doi.org/10.1098/rstb.2013.0164
-
The rh protein family: gene evolution, membrane biology, and disease associationCellular and Molecular Life Sciences 67:1203–1218.https://doi.org/10.1007/s00018-009-0217-x
-
Renal tubular acidosis: H+/base and ammonia transport abnormalities and clinical syndromesAdvances in Chronic Kidney Disease 25:334–350.https://doi.org/10.1053/j.ackd.2018.05.005
-
Nitrogen use efficiency in crops: lessons from Arabidopsis and riceJournal of Experimental Botany 68:2477–2488.https://doi.org/10.1093/jxb/erx101
-
Uniport of NH4+ by the root hair plasma membrane ammonium transporter LeAMT1;1Journal of Biological Chemistry 277:13548–13555.https://doi.org/10.1074/jbc.M200739200
Article and author information
Author details
Publication history
- Version of Record published: August 25, 2020 (version 1)
Copyright
© 2020, Allen and Collinson
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,891
- views
-
- 228
- downloads
-
- 1
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Ammonium Transporters: A molecular dual carriageway
eLife 9:e61148.
https://doi.org/10.7554/eLife.61148
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
DNA gyrase, a ubiquitous bacterial enzyme, is a type IIA topoisomerase formed by heterotetramerisation of 2 GyrA subunits and 2 GyrB subunits, to form the active complex. DNA gyrase can loop DNA around the C-terminal domains (CTDs) of GyrA and pass one DNA duplex through a transient double-strand break (DSB) established in another duplex. This results in the conversion from a positive (+1) to a negative (–1) supercoil, thereby introducing negative supercoiling into the bacterial genome by steps of 2, an activity essential for DNA replication and transcription. The strong protein interface in the GyrA dimer must be broken to allow passage of the transported DNA segment and it is generally assumed that the interface is usually stable and only opens when DNA is transported, to prevent the introduction of deleterious DSBs in the genome. In this paper, we show that DNA gyrase can exchange its DNA-cleaving interfaces between two active heterotetramers. This so-called interface ‘swapping’ (IS) can occur within a few minutes in solution. We also show that bending of DNA by gyrase is essential for cleavage but not for DNA binding per se and favors IS. Interface swapping is also favored by DNA wrapping and an excess of GyrB. We suggest that proximity, promoted by GyrB oligomerization and binding and wrapping along a length of DNA, between two heterotetramers favors rapid interface swapping. This swapping does not require ATP, occurs in the presence of fluoroquinolones, and raises the possibility of non-homologous recombination solely through gyrase activity. The ability of gyrase to undergo interface swapping explains how gyrase heterodimers, containing a single active-site tyrosine, can carry out double-strand passage reactions and therefore suggests an alternative explanation to the recently proposed ‘swivelling’ mechanism for DNA gyrase (Gubaev et al., 2016).
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Vitamin B6 deficiency has been linked to cognitive impairment in human brain disorders for decades. Still, the molecular mechanisms linking vitamin B6 to these pathologies remain poorly understood, and whether vitamin B6 supplementation improves cognition is unclear as well. Pyridoxal 5’-phosphate phosphatase (PDXP), an enzyme that controls levels of pyridoxal 5’-phosphate (PLP), the co-enzymatically active form of vitamin B6, may represent an alternative therapeutic entry point into vitamin B6-associated pathologies. However, pharmacological PDXP inhibitors to test this concept are lacking. We now identify a PDXP and age-dependent decline of PLP levels in the murine hippocampus that provides a rationale for the development of PDXP inhibitors. Using a combination of small-molecule screening, protein crystallography, and biolayer interferometry, we discover, visualize, and analyze 7,8-dihydroxyflavone (7,8-DHF) as a direct and potent PDXP inhibitor. 7,8-DHF binds and reversibly inhibits PDXP with low micromolar affinity and sub-micromolar potency. In mouse hippocampal neurons, 7,8-DHF increases PLP in a PDXP-dependent manner. These findings validate PDXP as a druggable target. Of note, 7,8-DHF is a well-studied molecule in brain disorder models, although its mechanism of action is actively debated. Our discovery of 7,8-DHF as a PDXP inhibitor offers novel mechanistic insights into the controversy surrounding 7,8-DHF-mediated effects in the brain.
